- Home
- MRM vs CPIX Comparison
MRM vs CPIX Comparison
Compare MRM & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRM
- CPIX
- Stock Information
- Founded
- MRM 2000
- CPIX 1999
- Country
- MRM Japan
- CPIX United States
- Employees
- MRM N/A
- CPIX N/A
- Industry
- MRM Other Consumer Services
- CPIX Biotechnology: Pharmaceutical Preparations
- Sector
- MRM Consumer Discretionary
- CPIX Health Care
- Exchange
- MRM Nasdaq
- CPIX Nasdaq
- Market Cap
- MRM 12.2M
- CPIX 37.9M
- IPO Year
- MRM 2020
- CPIX 2009
- Fundamental
- Price
- MRM $1.04
- CPIX $2.67
- Analyst Decision
- MRM
- CPIX
- Analyst Count
- MRM 0
- CPIX 0
- Target Price
- MRM N/A
- CPIX N/A
- AVG Volume (30 Days)
- MRM 169.4K
- CPIX 387.1K
- Earning Date
- MRM 01-01-0001
- CPIX 03-04-2025
- Dividend Yield
- MRM N/A
- CPIX N/A
- EPS Growth
- MRM N/A
- CPIX N/A
- EPS
- MRM N/A
- CPIX N/A
- Revenue
- MRM $44,462,062.00
- CPIX $36,785,442.00
- Revenue This Year
- MRM N/A
- CPIX N/A
- Revenue Next Year
- MRM N/A
- CPIX N/A
- P/E Ratio
- MRM N/A
- CPIX N/A
- Revenue Growth
- MRM 2.80
- CPIX N/A
- 52 Week Low
- MRM $0.90
- CPIX $1.04
- 52 Week High
- MRM $8.39
- CPIX $3.93
- Technical
- Relative Strength Index (RSI)
- MRM 33.50
- CPIX 67.72
- Support Level
- MRM $0.98
- CPIX $2.21
- Resistance Level
- MRM $1.17
- CPIX $2.40
- Average True Range (ATR)
- MRM 0.09
- CPIX 0.29
- MACD
- MRM 0.06
- CPIX -0.02
- Stochastic Oscillator
- MRM 22.19
- CPIX 33.78
About MRM MEDIROM Healthcare Technologies Inc.
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.